Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II
about
Molecular cloning of a novel human I-mfa domain-containing protein that differently regulates human T-cell leukemia virus type I and HIV-1 expressionPITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoterTranscription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stagesRelief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoterhnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongationTranscriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent mannerCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionFF domains of CA150 bind transcription and splicing factors through multiple weak interactionsTIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genesThe HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase IIThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzymeRelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actionsThe HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitroTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionTat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexesRequirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcriptionC-terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV-1 and adenovirus 2 major late templatesTFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcriptionRegulation of carboxyl-terminal domain phosphatase by HIV-1 tat proteinTAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell linesImpact of Genetic Variations in HIV-1 Tat on LTR-Mediated Transcription via TAR RNA InteractionTranscriptional control by cell-cycle regulators: a review.Multifaceted activities of the HIV-1 transactivator of transcription, Tat.Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell linesHuman and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.Human GLI-2 is a tat activation response element-independent Tat cofactor.Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3'-end cleavageThe molecular biology of bovine immunodeficiency virus: a comparison with other lentiviruses.Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin TRecruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment.Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.The Mediator complex and transcription elongation.The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism.
P2860
Q22253171-C9CDBD7F-463D-4C04-BE04-93C90EC167D0Q24523183-910368F5-C246-4886-96F0-4D2FEDA4BEA9Q24523709-2A697852-18B2-4027-84BB-0759B6C9637DQ24533266-8DDF1BEB-F2F0-42FC-8780-20CF960414B5Q24552532-26BD7E79-7109-4960-BDF5-329864AF66B7Q24554421-571AAFDF-A6D9-4A4D-A8D9-CBC77E4F9775Q24554483-50EFB97E-D2C4-4E51-A57A-7745AED6BBB7Q24559797-17B3A72C-EAD2-40F9-AEA2-FE0FC33BF684Q24563484-152EC4CA-2FA2-4C5E-8D2C-E1654ECC612DQ24600874-DB4FE114-755E-4417-871D-74648F77211DQ24605935-7E21F437-7DB8-419A-9A21-74B152772CBCQ24646774-3570D6EF-D9D6-4E99-8C25-8C1F45FD197FQ24673698-307D1B75-06C7-4C50-82C6-21917C3E32DBQ27486255-59B8BCF7-301C-49C1-96E1-C7D754EE04B3Q28116305-0B0D7C03-2C83-45E8-B7A9-EA42DD2C3DA3Q28138220-1C07932F-7DA8-4E75-863A-4158E698868AQ28141637-021441C4-F2BE-4360-A2D4-A4BAEBF4CB31Q28143301-C77132DF-3D5A-435E-BE54-435A8378852BQ28188877-6F82D53E-6E6E-481F-AA63-7EC47C4BE4A2Q28289216-17A1A65A-BDC2-4199-931D-11547BC4A93BQ28647556-57154748-0FF7-4131-B8A3-9FC12C8C9893Q33587964-57AC208A-E9AF-4C2A-84CA-F85298A9F419Q33591923-2247CCAC-DE24-4C6C-A1B1-A8A5AF4A0C9EQ33743566-4FACD7C9-A3EF-4441-AF45-B80D76E4CAF5Q33782959-653E3B6B-FDDA-4B84-993B-4575F7303CAAQ33786066-78818406-5A96-4369-AA0F-E2A24A072131Q33815080-C2083B3C-6734-4F70-B715-FCE876B1CB95Q33815308-2BCEC3A2-8343-4ACA-BC5F-33ECD5825332Q33850701-8725F000-3DF5-48C4-BF6F-825E4D83DF1AQ33957746-007FC453-BC96-4F0E-A356-6571BE01A062Q33958031-AC67F273-D78B-4C43-9D9A-8BBC7105B1BAQ34365622-3BF65C41-07EA-4C0D-BF84-798CEA01C4C9Q34429580-35BDB155-CA3C-4C04-8A84-EC5DC86DB5C7Q34669645-813AEB37-62EA-4343-93FF-6DA5BB54A1BFQ34987620-B12FF41B-C1FC-4B44-A19F-845D4B33B8FCQ36405698-F1D1F854-61E5-4D81-BD8A-70E394E6326EQ36573810-756496D1-F142-456C-95F7-0FE6DDE63D33Q37331647-01D7A761-4469-4205-8828-65343647E4F0Q38043907-F45897E1-42B8-45B1-B887-8A3C43F9B10CQ38292349-45E81279-54EA-4BFD-9719-ED164991B8F3
P2860
Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Trans-activation by human immu ...... al domain of RNA polymerase II
@ast
Trans-activation by human immu ...... al domain of RNA polymerase II
@en
Trans-activation by human immu ...... al domain of RNA polymerase II
@nl
type
label
Trans-activation by human immu ...... al domain of RNA polymerase II
@ast
Trans-activation by human immu ...... al domain of RNA polymerase II
@en
Trans-activation by human immu ...... al domain of RNA polymerase II
@nl
prefLabel
Trans-activation by human immu ...... al domain of RNA polymerase II
@ast
Trans-activation by human immu ...... al domain of RNA polymerase II
@en
Trans-activation by human immu ...... al domain of RNA polymerase II
@nl
P2093
P2860
P356
P1476
Trans-activation by human immu ...... al domain of RNA polymerase II
@en
P2093
B M Peterlin
C T Sheline
J L Corden
P2860
P304
P356
10.1073/PNAS.93.21.11575
P407
P577
1996-10-15T00:00:00Z